Andie Collier

Mrs. Collier has served as Senior Vice President, Regulatory Affairs since August 2021.

Andie has over twenty-five years of regulatory affairs and quality experience with drugs, biologics, medical devices, and drug/ device combination, encompassing a broad understanding of phase I-IV clinical trials development and management ranging from feasibility to commercial marketing. She has worked on over 80 successful INDs and 60 NDAs with the FDA, in oncology, dermatology and cardiology divisions. She has also shepherded several regulatory approvals in Europe, Australia, Latin America, Japan, and other Asian regulatory agencies. Andie was most recently the Sr Vice President of Regulatory Affairs at Glenmark Pharmaceuticals and held positions of increasing executive experience in several biopharma companies, including Gilead, BTG, Johnson & Johnson & Merck.

She is a pharmacist and holds a MSc in Regulatory Affairs from University of Southern California.